These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37944700)
1. Lung Cancer Risk Prediction Models for Asian Ever-Smokers. Yang JJ; Wen W; Zahed H; Zheng W; Lan Q; Abe SK; Rahman MS; Islam MR; Saito E; Gupta PC; Tamakoshi A; Koh WP; Gao YT; Sakata R; Tsuji I; Malekzadeh R; Sugawara Y; Kim J; Ito H; Nagata C; You SL; Park SK; Yuan JM; Shin MH; Kweon SS; Yi SW; Pednekar MS; Kimura T; Cai H; Lu Y; Etemadi A; Kanemura S; Wada K; Chen CJ; Shin A; Wang R; Ahn YO; Shin MH; Ohrr H; Sheikh M; Blechter B; Ahsan H; Boffetta P; Chia KS; Matsuo K; Qiao YL; Rothman N; Inoue M; Kang D; Robbins HA; Shu XO J Thorac Oncol; 2024 Mar; 19(3):451-464. PubMed ID: 37944700 [TBL] [Abstract][Full Text] [Related]
2. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study. Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223 [TBL] [Abstract][Full Text] [Related]
3. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening. Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127 [TBL] [Abstract][Full Text] [Related]
4. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis. Feng X; Goodley P; Alcala K; Guida F; Kaaks R; Vermeulen R; Downward GS; Bonet C; Colorado-Yohar SM; Albanes D; Weinstein SJ; Goldberg M; Zins M; Relton C; Langhammer A; Skogholt AH; Johansson M; Robbins HA Lancet Digit Health; 2024 Sep; 6(9):e614-e624. PubMed ID: 39179310 [TBL] [Abstract][Full Text] [Related]
6. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442 [TBL] [Abstract][Full Text] [Related]
9. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models. Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308 [TBL] [Abstract][Full Text] [Related]
10. Risk-stratified Approach for Never- and Ever-Smokers in Lung Cancer Screening: A Prospective Cohort Study in China. Wang F; Tan F; Shen S; Wu Z; Cao W; Yu Y; Dong X; Xia C; Tang W; Xu Y; Qin C; Zhu M; Li J; Yang Z; Zheng Y; Luo Z; Zhao L; Li J; Ren J; Shi J; Huang Y; Wu N; Shen H; Chen W; Li N; He J Am J Respir Crit Care Med; 2023 Jan; 207(1):77-88. PubMed ID: 35900139 [No Abstract] [Full Text] [Related]
11. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model. Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413 [TBL] [Abstract][Full Text] [Related]
12. Lung Cancer Absolute Risk Models for Mortality in an Asian Population using the China Kadoorie Biobank. Warkentin MT; Tammemägi MC; Espin-Garcia O; Budhathoki S; Liu G; Hung RJ J Natl Cancer Inst; 2022 Dec; 114(12):1665-1673. PubMed ID: 36083018 [TBL] [Abstract][Full Text] [Related]
13. Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Barry SA; Tammemagi MC; Penek S; Kassan EC; Dorfman CS; Riley TL; Commin J; Taylor KL J Natl Cancer Inst; 2012 Nov; 104(21):1647-59. PubMed ID: 23104210 [TBL] [Abstract][Full Text] [Related]
14. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. Choi E; Sanyal N; Ding VY; Gardner RM; Aredo JV; Lee J; Wu JT; Hickey TP; Barrett B; Riley TL; Wilkens LR; Leung AN; Le Marchand L; Tammemägi MC; Hung RJ; Amos CI; Freedman ND; Cheng I; Wakelee HA; Han SS J Natl Cancer Inst; 2022 Jan; 114(1):87-96. PubMed ID: 34255071 [TBL] [Abstract][Full Text] [Related]
16. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study. Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J Elife; 2023 Mar; 12():. PubMed ID: 36971353 [TBL] [Abstract][Full Text] [Related]
17. Lung cancer risk score for ever and never smokers in China. Ma Z; Lv J; Zhu M; Yu C; Ma H; Jin G; Guo Y; Bian Z; Yang L; Chen Y; Chen Z; Hu Z; Li L; Shen H Cancer Commun (Lond); 2023 Aug; 43(8):877-895. PubMed ID: 37410540 [TBL] [Abstract][Full Text] [Related]
18. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years. Bhardwaj M; Schöttker B; Holleczek B; Brenner H Lung Cancer; 2022 Dec; 174():83-90. PubMed ID: 36356492 [TBL] [Abstract][Full Text] [Related]
19. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525 [TBL] [Abstract][Full Text] [Related]
20. Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening. Gu F; Cheung LC; Freedman ND; Katki HA; Caporaso NE J Thorac Oncol; 2017 Nov; 12(11):1646-1653. PubMed ID: 28818607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]